Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -192,802 | -135,905 | -71,138 | -239,376 | -154,163 |
| Depreciation Amortization | 10,433 | 6,784 | 3,240 | 6,041 | 3,564 |
| Income taxes - deferred | -9,114 | -8,473 | -7,356 | -2,760 | -1,558 |
| Accounts receivable | -10,285 | -8,992 | 115 | 33 | 89 |
| Accounts payable and accrued liabilities | 1,365 | 7,886 | -4,455 | 21,783 | 16,746 |
| Other Working Capital | 3,867 | 32,013 | -11,548 | 211,628 | 179,503 |
| Other Operating Activity | 76,169 | 53,319 | 32,977 | 9,976 | 5,680 |
| Operating Cash Flow | $-120,367 | $-53,368 | $-58,165 | $7,325 | $49,861 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -623,243 | -375,629 | -150,519 | -1,315,597 | -724,714 |
| PPE Investments | -17,795 | -11,444 | -4,036 | -28,184 | -23,336 |
| Net Acquisitions | -74,575 | -74,575 | -74,575 | -77,666 | -77,666 |
| Sale Of Investment | 767,147 | 508,945 | 303,315 | 459,381 | 140,158 |
| Investing Cash Flow | $51,534 | $47,297 | $74,185 | $-962,066 | $-685,558 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -274 | -180 | -87 | -249 | -165 |
| Common Stock Issued | 50,254 | 49,311 | 47,679 | 851,487 | 849,020 |
| Common Stock Repurchased | -10,073 | -10,073 | N/A | N/A | 0 |
| Financing Cash Flow | $39,907 | $39,058 | $47,592 | $851,238 | $848,855 |
| Exchange Rate Effect | -52 | -42 | -3 | -67 | 11 |
| Beginning Cash Position | 252,398 | 252,398 | 252,398 | 355,968 | 355,968 |
| End Cash Position | 223,420 | 285,343 | 316,007 | 252,398 | 569,137 |
| Net Cash Flow | $-28,978 | $32,945 | $63,609 | $-103,570 | $213,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,367 | -53,368 | -58,165 | 7,325 | 49,861 |
| Capital Expenditure | -17,795 | -11,444 | -4,036 | -28,184 | -23,336 |
| Free Cash Flow | -138,162 | -64,812 | -62,201 | -20,859 | 26,525 |